Company page
Advagene Biopharma Co., Ltd.
Advagene Biopharma Co., Ltd. is a publicly traded company on the Taiwan stock market under the ticker 6709. The company has a market capitalization of approximately 55.5 million USD. Advagene focuses on biopharmaceutical development, contributing to advancements in healthcare solutions.

- Ticker
- 6709
- Market cap
- $55.5M
- Sector
- Health Technology
- Industry
- Biotechnology